New Alzheimer's drug hailed as 'beginning of the end' in search for treatment | Harwich and Manningtree Standard
Lecanemab was found to slow decline in patients’ memory and thinking.
Stay updated with breaking news from Bart De Strooper. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lecanemab was found to slow decline in patients’ memory and thinking.
Lecanemab was found to slow decline in patients’ memory and thinking.
A clinical trial of a drug has proven that it can help slow down cognitive decline in patients with early stage Alzheimer's, the most common type of dementia.
The trial involves nearly 1,800 people — divided between those given the medicine and those given a placebo — and runs over 18 months
TOKYO: Experts hailed full data showing a new drug can slow cognitive decline in Alzheimer's patients, but warned improvements were comparatively small and the treatment can have serious side...